Login
Super Investors / Invesco NASDAQ Future Gen 200 ETF

Invesco NASDAQ Future Gen 200 ETF

Invesco Exchange-traded Fund Trust Ii · net assets $14.1M · 205 holdings as of February 28, 2026. Monthly N-PORT disclosure: the full book, not just equities.

Asset mix

EC: 76.0% · STIV: 24.0%

Financial position

Total assets
$18.5M
Total liabilities
$4.44M
Net assets
$14.1M
Assets attributable to miscellaneous securities
$0
Assets invested in controlled foreign corporations
$0
Borrowings payable within one year
$0
Payable to controlled companies within one year
$0
Payable to other affiliates within one year
$0
Other liabilities payable within one year
$0
Borrowings payable after one year
$0
Payable to controlled companies after one year
$0
Payable to other affiliates after one year
$0
Other liabilities payable after one year
$0
Payables for delayed-delivery investments
$0
Payables for standby commitments
$0
Liquidation preference of outstanding preferred stock
$0
Cash not reported in Parts C or D
$0

Monthly flows and gains

Month 1 Month 2 Month 3
Sales $3.07M $0 $1.42M
Reinvestment $0 $0 $0
Redemptions $3.13M $0 $0
Net realized gain (non-derivative) $1.11M $-11.7K $-0.01
Net unrealized appreciation (non-derivative) $-1.06M $375K $306K

The three months of the reporting period, as filed; month 3 ends February 28, 2026.

Filing details

Registrant
Invesco Exchange-traded Fund Trust Ii
Registrant CIK
1378872
Registrant LEI
O540V2L4S174Y60FMD36
Series
Invesco NASDAQ Future Gen 200 ETF
Series ID
S000077288
Series LEI
549300GPI35ZCTF27915
SEC file number
811-21977
Address
3500 Lacey Road, Suite 700, Downers Grove, US-IL, 60515, US
Phone
800-983-0903
Form
NPORT-P
Filed
April 28, 2026
Report period ends
August 31, 2026
Report month ends
February 28, 2026
Accession number
000137887226000835
Holding Value % of net assets
Invesco Private Prime Fund STIV $3.2M 22.76%
Invesco Private Government Fund STIV $1.23M 8.76%
Axt, Inc. EC $234K 1.67%
Innovative Solutions And Support, Inc. EC $176K 1.25%
Allogene Therapeutics, Inc. EC $126K 0.90%
Neogen Corp. EC $124K 0.88%
Shattuck Labs, Inc. EC $124K 0.88%
Alector, Inc. EC $121K 0.86%
Entegris, Inc. EC $114K 0.81%
Vanda Pharmaceuticals Inc. EC $110K 0.78%
Viavi Solutions Inc. EC $110K 0.78%
Ipg Photonics Corp. EC $109K 0.78%
Mitek Systems, Inc. EC $109K 0.77%
Aehr Test Systems EC $108K 0.77%
Silicon Laboratories Inc. EC $106K 0.76%
Nlight, Inc. EC $106K 0.75%
Echostar Corp. EC $104K 0.74%
Mks Inc. EC $103K 0.73%
Iovance Biotherapeutics, Inc. EC $103K 0.73%
Fossil Group, Inc. EC $103K 0.73%
Kulicke And Soffa Industries, Inc. EC $102K 0.73%
Diodes Inc. EC $97.8K 0.69%
Cerus Corp. EC $96.3K 0.68%
Silicon Motion Technology Corp. EC $96.1K 0.68%
Anika Therapeutics, Inc. EC $96K 0.68%
Amicus Therapeutics, Inc. EC $95.8K 0.68%
Cognex Corp. EC $94.5K 0.67%
Power Integrations, Inc. EC $94.4K 0.67%
Geron Corp. EC $94.2K 0.67%
Vir Biotechnology, Inc. EC $93.6K 0.66%
Littelfuse, Inc. EC $91.3K 0.65%
Allegro Microsystems, Inc. EC $90.4K 0.64%
Lattice Semiconductor Corp. EC $90.2K 0.64%
Everspin Technologies, Inc. EC $89.1K 0.63%
Viasat, Inc. EC $88.3K 0.63%
Orasure Technologies, Inc. EC $87.8K 0.62%
Amkor Technology, Inc. EC $87K 0.62%
Dentsply Sirona Inc. EC $85.9K 0.61%
Fate Therapeutics, Inc. EC $85.8K 0.61%
Align Technology, Inc. EC $85.7K 0.61%
Agora, Inc. EC $85.6K 0.61%
Gsi Technology, Inc. EC $84.8K 0.60%
Millerknoll, Inc. EC $84.2K 0.60%
Cytomx Therapeutics, Inc. EC $82.9K 0.59%
Newell Brands Inc. EC $82.6K 0.59%
Omeros Corp. EC $82.3K 0.58%
Cohu, Inc. EC $82.1K 0.58%
Garrett Motion Inc. EC $81.4K 0.58%
Coherus Oncology, Inc. EC $81.4K 0.58%
Masimo Corp. EC $81.4K 0.58%
10x Genomics, Inc. EC $81K 0.58%
Semtech Corp. EC $80.6K 0.57%
Biocryst Pharmaceuticals, Inc. EC $80.5K 0.57%
Pro-dex, Inc. EC $80.5K 0.57%
Autolus Therapeutics PLC EC $80.4K 0.57%
Sleep Number Corp. EC $80K 0.57%
Tandem Diabetes Care, Inc. EC $79.6K 0.57%
Synaptics Inc. EC $78.6K 0.56%
Enlivex Ltd. EC $78.4K 0.56%
Johnson Outdoors Inc. EC $78.3K 0.56%

Showing top 60 of 205 holdings.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support